Related Experiment Videos
Progesterone receptor A and B isoform expression in human osteoblasts
1Center for Experimental Therapeutics, University of Pennsylvania, 804 Stellar Chance Laboratories, 422 Curie Boulevard, Philadelphia, Pennsylvania 19104, USA.
Calcified Tissue International
|June 26, 1998
Summary
Human osteosarcoma cells express progesterone receptors (PR) isoforms. Beta-estradiol stimulates PR promoter activity, indicating progesterone influences bone-forming cells.
Area of Science:
- Endocrinology
- Molecular Biology
- Bone Biology
Background:
- Human progesterone receptors (PR) are known to be expressed in osteosarcoma cells and primary osteoblasts.
- Understanding the specific isoforms and their regulation is crucial for comprehending hormonal influence on bone cells.
Purpose of the Study:
- To investigate the expression of progesterone receptor alpha (PRa) and progesterone receptor beta (PRb) isoforms in human osteosarcoma cells.
- To analyze the effect of beta-estradiol on the promoter activity of both PRa and PRb in human osteosarcoma cell lines.
Main Methods:
- Rapid amplification of 5' cDNA ends (5'RACE) was utilized to detect PR mRNA transcripts for both isoforms.
- Southern blot analysis confirmed the specificity of amplified PR products.
- Chimeric recombinants of PRa and PRb promoter regions were transiently expressed in osteosarcoma cell lines to assess promoter activity.
Main Results:
- PR mRNA transcripts coding for both PRa and PRb isoforms were detected in the HOS-TE85 osteosarcoma cell line and MCF-7 breast cancer cells.
- Southern blot confirmed the specificity of the amplified PR products, identifying distinct transcripts for PRa and PRb isoforms.
- Beta-estradiol significantly induced both PRa and PRb promoter activity across all three tested human osteosarcoma cell lines (HOS-TE85, MG-63, SAOS-2).
Conclusions:
- Human osteosarcoma cells express both PRa and PRb mRNA transcripts.
- The promoters for both PRa and PRb isoforms are responsive to beta-estradiol.
- These findings support the physiological influence of progesterone on bone-forming cells via estrogen-responsive PR promoters.